<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="204610">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    https://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2015</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00000363</url>
  </required_header>
  <id_info>
    <org_study_id>NIDCD-1160</org_study_id>
    <secondary_id>RO1 DC 02620-04</secondary_id>
    <nct_id>NCT00000363</nct_id>
  </id_info>
  <brief_title>Acute Otitis Media: Adjuvant Therapy to Improve Outcome</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Institute on Deafness and Other Communication Disorders (NIDCD)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Institute on Deafness and Other Communication Disorders (NIDCD)</source>
  <oversight_info>
    <authority>United States: Federal Government</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      Acute otitis media is one of the most common diseases of childhood and is one of the major
      causes of hearing loss in children. Despite the availability of effective antibiotic therapy
      for otitis media, treatment failures, persistent effusions, and recurrences are common. This
      Phase III outpatient study aims to test whether adjuvant therapy (an antihistamine or a
      corticosteroid), in addition to antibiotic therapy, improves the acute and long-term
      outcomes of patients with acute otitis media. This study is targeted to recruiting 200
      infants (age less than one year); patient (and parent) participation is estimated to
      continue for one year after enrollment.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <completion_date>June 2001</completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Masking: Double-Blind, Primary Purpose: Treatment</study_design>
  <condition>Otitis Media</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Antihistamine</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Corticosteroid</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Have had two documented prior episodes of acute otitis media.

          -  Have no current middle ear effusion (fluid).

        Exclusion Criteria:

          -  Have chronic otitis media.

          -  Have acute otitis media in addition to chronic otitis media.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>2 Months</minimum_age>
    <maximum_age>1 Year</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dr. Tasnee Chonmaitree</last_name>
    <role>Study Chair</role>
  </overall_official>
  <location>
    <facility>
      <name>Univ of Texas Med Branch Children's Hosp</name>
      <address>
        <city>Galveston</city>
        <state>Texas</state>
        <zip>77550</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Chonmaitree T, Saeed K, Uchida T, Heikkinen T, Baldwin CD, Freeman DH Jr, McCormick DP. A randomized, placebo-controlled trial of the effect of antihistamine or corticosteroid treatment in acute otitis media. J Pediatr. 2003 Sep;143(3):377-85.</citation>
    <PMID>14517524</PMID>
  </reference>
  <reference>
    <citation>McCormick DP, Saeed K, Uchida T, Baldwin CD, Deskin R, Lett-Brown MA, Heikkinen T, Chonmaitree T. Middle ear fluid histamine and leukotriene B4 in acute otitis media: effect of antihistamine or corticosteroid treatment. Int J Pediatr Otorhinolaryngol. 2003 Mar;67(3):221-30.</citation>
    <PMID>12633920</PMID>
  </reference>
  <verification_date>April 2006</verification_date>
  <lastchanged_date>April 21, 2006</lastchanged_date>
  <firstreceived_date>November 2, 1999</firstreceived_date>
  <keyword>Antibiotics</keyword>
  <keyword>Adrenal Cortex Hormones</keyword>
  <keyword>Histamine H1 Antagonists</keyword>
  <keyword>Infant</keyword>
  <keyword>Otitis Media</keyword>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Otitis</mesh_term>
    <mesh_term>Otitis Media</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Histamine Antagonists</mesh_term>
    <mesh_term>Histamine H1 Antagonists</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
